This document is a publication of a European patent application (EP4630013A1) related to methods for identifying and isolating T cell-comprising cell-cell complexes and their therapeutic applications. The patent application was filed by Stichting Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis and includes classifications in A61K (Medicinal preparations), A61P (Therapeutic activity of medicinal preparations), G01N (Investigating non-biological material), and C12N (Microorganisms; Enzymes; Molecular genetics).

As this is a patent publication, it does not impose direct compliance obligations or deadlines on regulated entities. However, it may inform future research and development strategies for companies in the pharmaceutical and biotechnology sectors, particularly those involved in cancer immunotherapy and cell-based therapies. Compliance officers should note this publication as it may indicate emerging intellectual property in a competitive landscape.